Pre-targeting of polymeric nanomaterials to balance tumour accumulation and clearance.
Nicholas L FletcherA PriorO ChoyJames HumphriesPie HudaSaikat GhoshZachary H HoustonCraig A BellKristofer J ThurechtPublished in: Chemical communications (Cambridge, England) (2022)
Pre-targeting of bispecific antibodies is probed to enhance tumour retention while limiting clearance of administered multifunctional branched PEGylated nanomedicines. The temporal influence of pre-targeting on polymer interaction with tumour cells and tissue is explored using in vitro assays through to preclinical validation.